Resources Contact Us Home
Binding peptides for carcinoembryonic antigen (CEA)

Image Number 5 for United States Patent #7438890.

The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.

  Recently Added Patents
Customizing a range of acceptable tape dimensional stability write conditions
Vibration disturbance estimation and control
Solar power system with communication network utilizing magnetic fields
Parasitic element compensation circuit and method for compensating for the parasitic element
Table base
Humidity indicator and method for fabricating the same
LED light
  Randomly Featured Patents
Construction assembly for closure structure
On-line mining of association rules
Downhole motor bearing assembly
Pullulanase variants and methods for preparing such variants with predetermined properties
Vehicle seat slide structure
Frame structure and method of making same
Multiple hull boat
Technique for locking a laser diode to a passive cavity
Computer controlled video system allowing playback during recording
Method and receptacle for receiving and releasing a pen